For following the competition: what moved in each program, several studies read as one move.
- pembrolizumab
- Radiosensitizer VS-101
- Anti-GPC3 Antibody-drug Conjugate ZW251
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add Neoplasms, Squamous Cell to watchlistEvery Monday by email · turn it off any timePro · free during the beta